Biochemical Engineering Special Interest Group
biological engineering professionals
26 September 2017

Next-gen CAR-T firm Autolus takes funding tally to $173M

London-based CAR-T player Autolus has raised $80 million in a third-round financing that it says will fund proof-of-concept testing for three programs. The company’s established investors, Syncona, Woodford, and Arix Bioscience, have been joined by new backers including Cormorant Asset Management and Nextech Invest, taking the total amount of financing raised by Autolus to date to around $173 million. Source: FierceBiotech 26/9/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).